Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study
J. Anthony Gomes, MD, FACCa,
John Ip, MD, FACC*,
Francesco Santoni-Rugiu, MDa,
Davendra Mehta, MD, PhD, FACCa,
Arisan Ergin, MDa,
Steven Lansman, MDa,
Elena Pe, RN, NPa,
Teri Takle Newhouse, MS
and
Sally Chao, BSa
a Electrophysiology and Electrocardiography Section, the Zena and Michael Wiener Cardiovascular Institute, Department of Medicine, The Mount Sinai School of Medicine and the Mount Sinai Medical Center, New York, New York, USA
* Thoracic Cardiovascular Institute, Lansing, Michigan, USA
Biostatistics Department, Medronic, Minneapolis, Minnesota, USA

View larger version (10K):
[in a new window]
|
Figure 1 Kaplan-Meier analysis of the percentage of patients free of atrial fibrillation on sotalol as compared to placebo. The abscissa plots the time in days, and the ordinate plots the percentage of patients free of AF.
|
|
Copyright © 1999 by the American College of Cardiology Foundation.